CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,234,545 | -3.0% | 600,012 | +20.0% | 0.42% | +2.7% |
Q2 2023 | $28,070,000 | -24.7% | 500,000 | -39.3% | 0.41% | -24.4% |
Q1 2023 | $37,269,520 | -11.5% | 824,000 | -20.5% | 0.54% | -26.9% |
Q4 2022 | $42,113,400 | -30.3% | 1,036,000 | +12.1% | 0.74% | -29.8% |
Q3 2022 | $60,383,000 | -0.6% | 924,000 | -7.6% | 1.05% | -1.2% |
Q2 2022 | $60,770,000 | -5.5% | 1,000,000 | -2.3% | 1.06% | -14.7% |
Q1 2022 | $64,276,000 | -4.9% | 1,024,000 | +14.8% | 1.24% | +12.4% |
Q4 2021 | $67,596,000 | +58.9% | 892,000 | +134.7% | 1.11% | +53.6% |
Q3 2021 | $42,533,000 | +66.3% | 380,000 | +140.5% | 0.72% | +57.2% |
Q2 2021 | $25,579,000 | +34.6% | 158,000 | +1.3% | 0.46% | +5.0% |
Q1 2021 | $19,009,000 | +72.4% | 156,000 | +116.7% | 0.44% | +16.3% |
Q4 2020 | $11,024,000 | -35.4% | 72,000 | -64.7% | 0.38% | -39.4% |
Q3 2020 | $17,063,000 | +23.5% | 204,000 | +8.5% | 0.62% | +2.1% |
Q2 2020 | $13,816,000 | +38.0% | 188,000 | -20.3% | 0.61% | -2.1% |
Q1 2020 | $10,009,000 | +11.0% | 236,000 | +59.5% | 0.62% | +19.0% |
Q4 2019 | $9,014,000 | -16.7% | 148,000 | -43.9% | 0.52% | -27.5% |
Q3 2019 | $10,821,000 | +278.6% | 264,000 | +230.0% | 0.72% | +359.6% |
Q1 2019 | $2,858,000 | -41.8% | 80,000 | -53.5% | 0.16% | -58.1% |
Q4 2018 | $4,914,000 | -32.6% | 172,000 | +38.7% | 0.37% | -21.8% |
Q2 2018 | $7,286,000 | – | 124,000 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |